Author

Zhenwei Shen

Observed names: Shen, Zhen-Wei, Zhen-Wei Shen, Zhenghai Shen, Zhen‐Wei Shen

Observed institutions: Jiangsu University, Zhejiang Shuren University, Yixing People's Hospital, CStone Pharmaceuticals (China), Nanjing Medical University

ORCID: 0000-0002-7869-022X

Observed ORCID: 0000-0002-7869-022X

OpenAlex ID: A5020191359

First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial

2025 · Xiaotian Zhang, Jufeng Wang, et al. · JAMA · 93

Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development

2021 · Keda Chen, Chaonan Li, et al. · Vaccines · 8

PDF

Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults

2023 · Gui-Ling Chen, Xu-Ya Yu, et al. · Vaccine · 6

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

2023 · Guiling Chen, Nan Li, et al. · Infectious Diseases and Therapy · 6

PDF

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single‐Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double‐Blind, Placebo‐Controlled Study

2025 · Zhen‐Wei Shen, Ting‐Han Jin, et al. · Clinical and Translational Science · 4

PDF

Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study

2024 · Mingyuan Sun, Qingsong Yin, et al. · Blood Science · 4

Primary closure with self-disengaging biliary stent following laparoscopic CBD exploration in normal-diameter ducts: a propensity score matching study

2025 · Feng Zhan, Chao Jiang, et al. · Scientific Reports · 3

PDF

Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study

2024 · Zhen-Wei Shen, Kai-Qi Wu, et al. · Rheumatology and Therapy · 2

circSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis

2021 · Xiaotian Yu, Yun Zhang, et al. · Journal of Oncology · 2

PDF

Surgical techniques for modular one-stage emergent pancreaticoduodenectomy for blunt abdominal trauma: experiences from three centres and a review of the literature

2025 · Xing Wang, Zitong Zhang, et al. · BMC Surgery · 1

PDF

Safety, tolerability, pharmacokinetics, and immunogenicity of JMB2002–an antibody against COVID-19: a phase 1 clinical trial in healthy Chinese adults

2023 · Guiling Chen, Ying Zhang, et al. · BMC Infectious Diseases · 1

PDF

Relaparoscopic common bile duct exploration for management of choledocholithiasis

2014 · Kai Zhang, Feng Zhan, et al. · Zhonghua gan-dan waike zazhi · 1

QX 008 N , an Anti‐ TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects

2026 · Zhen‐Wei Shen, Qi Jiang, et al. · Clinical and Translational Science

Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin‐4‐IgG4‐Fc in healthy subjects: A phase 1, single‐centre, randomized, double‐blind, dose escalation study

2024 · Gui‐Ling Chen, Yang Liu, et al. · Diabetes Obesity and Metabolism

PDF

Author response for "Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study"

2023 · Chen, Gui-Ling, Liu, Yang, et al. · Publons reviews and discussion

Application value of laparoscopic common bile duct re-exploration with primary closure for common bile duct stones

2016 · Yue Yang, Yun Zhang, et al.

Works count: 17

Citation count: 131

H-index: 4

I10-index: 1